Logotype for Pantheon International PLC

Pantheon International (PIN) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Pantheon International PLC

H2 2024 earnings summary

17 Feb, 2026

Executive summary

  • NAV per share grew 6.1% for the year ended 31 May 2024, with share price up 20% and discount to NAV narrowing to 34% at year-end.

  • Average annualized NAV growth was 13.5% over 10 years, outperforming major indices, with 13.7% annualized since inception.

  • £197m invested in share buybacks at a 35% discount, adding 4.7% to NAV; £200m buyback program completed post year-end.

  • Portfolio is diversified across direct investments (54%) and funds (46%), with a focus on high-growth sectors like IT and healthcare.

  • Portfolio companies delivered 17% EBITDA and 14% revenue growth, outperforming public benchmarks.

Financial highlights

  • Net assets at 31 May 2024 were £2.28bn, with NAV per share at 490.5p, up from 462.4p the prior year.

  • Five-year total shareholder return was 46.5%, and annualized NAV per share growth over 10 years was 13.5%.

  • Portfolio generated positive net cash flow of £37m for the year and £1.6bn over 10 years.

  • Weighted average uplift on exits was 20% for the year and 30% since 2012; average cost multiple at exit was 3.0x.

  • Ongoing charges ratio was 1.31% (1.87% including financing costs).

Outlook and guidance

  • New capital allocation policy from June 2024 links buybacks to share price discount and net portfolio cash flow, with quarterly reviews.

  • Board expects net leverage to remain below 10% of NAV under normal conditions.

  • Early signs of improvement in the M&A market; several portfolio companies are positioned for sale as conditions improve.

  • Enhanced marketing efforts aim to broaden the investor base, especially among UK retail and institutional investors.

  • Focus remains on long-term capital growth, not dividends.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more